| 1 |
HUANG C C , JONG M H , LIN S Y . Characteristics of foot and mouth disease virus in Taiwan[J]. J Vet Med Sci, 2000, 62 (7): 677- 679.
doi: 10.1292/jvms.62.677
|
| 2 |
DAVIES G . The foot and mouth disease (FMD) epidemic in the United Kingdom 2001[J]. Comp Immunol Microbiol Infect Dis, 2002, 25 (5-6): 331- 343.
doi: 10.1016/S0147-9571(02)00030-9
|
| 3 |
何继军, 马维民, 杨亚民, 等. 我国O型口蹄疫流行毒株分子溯源[J]. 中国兽医科学, 2019, 49增刊, 12- 15.
|
| 4 |
GRUBMAN M J , BAXT B . Foot-and-mouth disease[J]. Clin Microbiol Rev, 2004, 17 (2): 465- 493.
doi: 10.1128/CMR.17.2.465-493.2004
|
| 5 |
MATEU M G , CAMARERO J A , GIRALT E , et al. Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host[J]. Virology, 1995, 206 (1): 298- 306.
doi: 10.1016/S0042-6822(95)80045-X
|
| 6 |
LUDI A B , HORTON D L , LI Y , et al. Antigenic variation of foot-and-mouth disease virus serotype A[J]. J Gen Virol, 2014, 95 (2): 384- 392.
doi: 10.1099/vir.0.057521-0
|
| 7 |
BABA SHEIKH M O , RASHID P M A , MAROUF A S , et al. Phylogenic analysis of serotype Asia1 foot-and-mouth disease virus from Sulaimani/Iraq using VP1 protein: heterogeneity with vaccine strain As1/Shamir/89[J]. Iran J Vet Res, 2017, 18 (3): 212- 215.
|
| 8 |
LI P H , HUANG S L , ZHA J J , et al. Evaluation of immunogenicity and cross-reactive responses of vaccines prepared from two chimeric serotype O foot-and-mouth disease viruses in pigs and cattle[J]. Vet Res, 2022, 53 (1): 56.
doi: 10.1186/s13567-022-01072-7
|
| 9 |
FERNANDEZ-SAINZ I , GAVITT T D , KOSTER M , et al. The VP1 G-H loop hypervariable epitope contributes to protective immunity against Foot and Mouth Disease Virus in swine[J]. Vaccine, 2019, 37 (26): 3435- 3442.
doi: 10.1016/j.vaccine.2019.05.019
|
| 10 |
BORREGO B , CAMARERO J A , MATEU M G , et al. A highly divergent antigenic site of foot-and-mouth disease virus retains its immunodominance[J]. Viral Immunol, 1995, 8 (1): 11- 18.
doi: 10.1089/vim.1995.8.11
|
| 11 |
MATEU M G , HERNÁNDEZ J , MARTÍNEZ M A , et al. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites[J]. J Virol, 1994, 68 (3): 1407- 1417.
doi: 10.1128/jvi.68.3.1407-1417.1994
|
| 12 |
MATEU M G , MARTÍNEZ M A , CAPUCCI L , et al. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C[J]. J Gen Virol, 1990, 71 (3): 629- 637.
doi: 10.1099/0022-1317-71-3-629
|
| 13 |
SZCZEPANEK S M , BARRETTE R W , ROOD D , et al. Xenoepitope substitution avoids deceptive imprinting and broadens the immune response to foot-and-mouth disease virus[J]. Clin Vaccine Immunol, 2012, 19 (4): 461- 467.
doi: 10.1128/CVI.00035-12
|
| 14 |
ZAMORANO P , WIGDOROVITZ A , PEREZ-FILGUEIRA M , et al. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice[J]. Virology, 1995, 212 (2): 614- 621.
doi: 10.1006/viro.1995.1519
|
| 15 |
RIEDER E , BAXT B , LUBROTH J , et al. Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV[J]. J Virol, 1994, 68 (11): 7092- 7098.
doi: 10.1128/jvi.68.11.7092-7098.1994
|
| 16 |
BISWAL J K , RANJAN R , PATTNAIK B . Chimeric foot-and-mouth disease virus serotype O displaying a serotype Asia1 antigenic epitope at the surface[J]. Biotechnol Lett, 2016, 38 (9): 1509- 1517.
doi: 10.1007/s10529-016-2121-4
|
| 17 |
PAY T W F , HINGLEY P J . Foot and mouth disease vaccine potency test in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge[J]. Vaccine, 1992, 10 (10): 699- 706.
doi: 10.1016/0264-410X(92)90092-X
|